[1] |
Doyle LA. Sarcoma classification: an update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone [J]. Cancer, 2014, 120(12): 1763-1774.
|
[2] |
Kim DH, Murovic JA, Tiel RL, et al. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center [J]. J Neurosurg, 2005, 102(2): 246-255.
|
[3] |
Perrin RG , Guha A . Malignant peripheral nerve sheath tumors [J]. Neurosurg Clin N AM, 2004, 15(2): 203-216.
|
[4] |
Fletcher CD. The evolving classification of soft tissue tumors: an update based on the new WHO classification [J]. Histopathology, 2014, 64(1): 2-11.
|
[5] |
杨学军, 江涛. 解读《世界卫生组织中枢神经系统肿瘤分类(2016年)》[J]. 中国神经精神疾病杂志, 2016, 42(6): 321-329.
|
[6] |
LaFemina J, Qin LX, Moraco NH, et al. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors[J]. Ann Surg Oncol, 2013, 20(1): 66-72.
|
[7] |
L'Heureux-Lebeau B, Saliba I. Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors [J]. OncoTargets Ther, 2013, 6: 459-470.
|
[8] |
Bin Samsuddin MF, Bin Omar MA. Malignant peripheral nerve sheath tumor: treat or not treat[J]. Asian J Neurosurg, 2019, 14(1): 283-285.
|
[9] |
Stucky CC, Johnson KN, Gray RJ, et al. Malignant peripheral nerve sheath tumors (MPNST): the Mayo clinic experience [J]. Ann Surg Oncol, 2012, 19 (3): 878-885.
|
[10] |
Fan Q, Yang J, Wang G. Clinical and molecular prognostic predictors of malignant peripheral nerve sheath tumor [J]. Clin Transl Oncol, 2014, 16(2): 191-199.
|
[11] |
Valentina T, Le Cesne A, Ray-Coquard I, et al. Management and prognosis of malignant peripheral nerve sheath tumors: the experience of the French Sarcoma Group (GSF-GETO)[J]. Eur J Cancer, 2016, 56(1): 77-84.
|
[12] |
Von Mehren M, Randall RL, Benjamin RS, et al. Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2018, 16(5): 536-563.
|
[13] |
袁振南. 140例恶性外周神经鞘瘤的临床病理特征与预后影响因素分析[D]. 北京:北京协和医学院, 2017: 1-39.
|
[14] |
Reilly KM, Kim A, Blakely J, et al. Neurofibromatosis type 1-associated MPNST state of science: outlining a research agenda for the future [J]. J Natl Cancer Inst, 2017, 109(8):1-6.
|
[15] |
Schaefer IM, Hornick JL. Diagnostic immunohistochemistry for soft tissue and bone tumors: an update [J]. Adv Anat Pathol, 2018, 25(6): 400-412.
|
[16] |
Genadry KC, Pietrobono S, Rota R, et al. Soft tissue sarcoma cancer stem cells: an overview [J]. Front Oncol, 2018, 8(1): 475-481.
|
[17] |
Ray-Coquard I, Serre D, Reichardt P, et al. Options for treating different soft tissue sarcoma subtypes [J]. Future Oncol, 2018, 14(10s): 25-49.
|
[18] |
Bishop AJ, Zagars GK, Torres KE, et al. Malignant peripheral nerve sheath tumors: a single institution's experience using combined surgery and radiation therapy[J]. Am J Clin Oncol, 2018, 41(5): 465-470.
|